Established in 1993, Europ supplies medical devices, in vitro diagnostic and laboratory products in Cambodia.
With around 90 employees, the company distributes products from international clients such as Philips, B. Braun, Horiba and Agilent.
Europ provides its clients with services ranging from marketing to sales, distribution, logistics and after-sales.
The employees of Europ will gradually be incorporated in DKSH’s operations, including management team.
The acquisition will allow DKSH to expand its market leadership to the medical device, in vitro diagnostic and laboratory products sectors in Cambodia, as well as improve its position as the healthcare provider in Asia.
DKSH president and CEO Dr Joerg Wolle said: “With the acquisition of Europ Continents Cambodia, we are strengthening our position as the market leader in Cambodia; a country that is among the fastest-growing markets in Asia.
“As we expand our portfolio of medical devices and laboratory products, we can offer our customers an even broader range of healthcare products and services out of one hand. With that, we also underline our conviction in the strong economic future of the region.”
Europ Continents Holding chairman Jean Marc Beaujolin said: “With this acquisition, DKSH will improve its leading market position by providing our clients and customers access to even more growth opportunities. DKSH will further invest in our operations, our IT platform and our expertise.”
Since 60 years, the DKSH has been carrying out business operations in Cambodia.
With around 1,400 specialists, the company operates four business units such as consumer goods, healthcare, performance materials and technology in the country.
Image: Europ Continents Cambodia distributes medical devices, in vitro diagnostic and laboratory products. Photo: courtesy of DKSH Management Ltd.
